Registration Options

Activity Dates: 05/16/2019 - 04/09/2022

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

With the revisions to the DSM-5 as well as the recent focus on under-recognition and potential for increased mortality, the pharmacist needs to be competent in recognizing catatonia. Furthermore the psychiatric pharmacist needs to understand common rating scales to detect and measure severity of catatonic symptoms. It is also critical for any clinician treating patients with catatonia to note differences among malignant catatonia, NMS, and malignant hyperthermia since many symptoms overlap.

Also in this session, we will review common treatments for catatonia along with reviewing the evidence for common second and third line agents should the patient not respond or not have access to the usual first line treatments such as benzodiazepines and ECT.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course. (sign in first)
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (sign in first)
  • Complete the evaluation at the end of the activity. (sign in first)
  • If necessary, complete the post-test retest no later than the closing activity date. (sign in first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (sign in first)

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at

Faculty Information and Disclosures

Christopher Thomas PharmD, BCPP, BCPS

View biographical information and disclosures

Learning Objectives

  1. Recognize symptoms, common rating scales, and complications of catatonia
  2. Examine the role of pharmacotherapy and ECT in catatonia,
  3. Compare and contrast the evidence to support novel treatment strategies for the management of catatonia.
  4. Develop a treatment plan for someone with the diagnosis of catatonia.

Continuing Education Credit and Disclosures

Activity Dates: 05/16/2019 - 04/09/2022
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-19-032-H04-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hour of knowledge-based continuing education credit from CPNP approved programming.